Back to Markets
LELegend Biotech Corp

Legend Biotech Corp

LEGN
Health CareBiotechnology: Pharmaceutical Preparations

$27.16

-1.100000 (-3.89%)

As of 05/29/26 EDT · USD

Compare
Low: $16.24Current: $27.16High: $45.30

Key Statistics

Open

$28.26

Day High

$28.49

Day Low

$26.52

Prev. Close

$28.26

VolumeShares traded today.

2.34M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$5.04B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-16.87

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$45.30

52W LowLowest price over the past 52 weeks.

$16.24

50D MAAverage closing price over the last 50 trading days.

$23.18

200D MAAverage closing price over the last 200 trading days.

$25.89

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-3.0%

1M

+19.3%

6M

-3.7%

YTD

+26.3%

1Y

-6.2%

About

GenScript Biotech, fully known as GenScript Biotech Corporation, usually referred to as simply GenScript, is a Chinese biotech company. It was co-founded in 2002 in New Jersey by Fangliang Zhang, Ye Wang, and Luquan Wang. Headquartered in Nanjing, the company mainly provides life science research application instruments and services. It was listed on the Hong Kong Stock Exchange in 2015. The current rotating CEO of the firm is Shao Weihui, who also served as the chief operating officer and Chinese Communist Party Committee Secretary for the company. The company's main subsidiaries include Legend Biotech, ProBio Technology, and Bestzyme.

Company Facts

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade LEGN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.